US FDA is planning to prohibit fruity e-cigarette pod flavors

By Nikita Chaurasia  Date: 2020-01-03

US FDA is planning to prohibit fruity e-cigarette pod flavors

US FDA is planning to prohibit fruity e-cigarette pod flavors

The US FDA (Food and Drug Administration) is reportedly planning to prohibit the use of all the flavors of pod-based e-cigarette except tobacco and menthol. The move comes merely a while after the organization increased the age restriction for vaping and some other tobacco products to 21.

According to credible sources, the FDA’s plans regarding the ban over fruity pods might be declared as soon as Friday. Apparently, this ban would be inclusive of mint cartridges used in e-cigarettes. However, it has been stated that the ban would not further extend to fruity or any other flavor for tank vaping systems.

When asked about the administration’s plan to tackle the growing usage of vape by youth and rising health concerns due to these products, President Donald Trump indirectly stated that these flavor bans would not be permanent.

Trump stated that the agency would be taking off specific flavors for a certain period. The government, through this move, aims to protect families, children as well as the overall industry, he says, adding that hopefully, if everything goes well, these flavors would very quickly come back into the industry.

Trump further added that he thinks those flavors that are expected to be banned from the industry would be permitted again after an exhaustive examination.

The ban over fruity flavors comes in the wake of health regulators struggling with tackling a massive increase in the percentage of young people using vape products. In fact, the agency announced recently that an amendment to the Federal Food, Drug, and Cosmetic Act to increase the minimum age to buy tobacco’s product from 18 to 21 was authorized.

In anticipation of this flavor ban, Juul, the highly popular product used by teens and kids because of its USB-style design and its fruity flavors available earlier — removed all of its non-tobacco and non-menthol flavors from sale earlier in 2019.

 

Source credit: https://gizmodo.com/fda-is-reportedly-preparing-to-ban-fruity-e-cigarette-p-1840761898

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

By Nikita Chaurasia

Leading Testing as a Service (TaaS) provider, 1health, recently announced that it has partnered with SkyWest Airlines, a SkyWest Inc. subsidiary, to provide two types of COVID-19 tests to the airline’s personnel. Mehdi Maghsoodnia, CEO at 1hea...

FBI to remove backdoors from hacked Microsoft Exchange email servers

FBI to remove backdoors from hacked Microsoft Exchange email servers

By Nikita Chaurasia

Following the recent cyber-attack in the US, a court in Houston has reportedly authorized a new FBI operation to copy and eliminate backdoors from large number of Microsoft Exchange email servers across the country. During this hacking event, the hac...

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...